Dr. Nader S. Eldika, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,004
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
KS license 04-32249 -
Critical Care Medicine (Internal Medicine) Physician
KS license 04-32249 -
Internal Medicine Physician
KS license 04-32249 -
Sleep Medicine (Internal Medicine) Physician
KS license 04-32249
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Wesley Medical Center Wichita, KS
- William Newton Hospital Winfield, KS
- Neosho Memorial Regional Medical Center Chanute, KS
- Fredonia Regional Hospital Fredonia, KS
- Hospital District #6 PAtterson Health Center Anthony, KS
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,004
- Services billed
- 2,710
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 939 | 152 |
| Established patient office or other outpatient visit, 30-39 minutes | 708 | 512 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 222 | 125 |
| Test to determine lung volumes using gas dilution or washout | 180 | 180 |
| Test to examine how well the lungs exchange gases | 180 | 180 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 177 | 177 |
| Established patient office or other outpatient visit, 20-29 minutes | 177 | 169 |
| New patient office or other outpatient visit, 45-59 minutes | 161 | 161 |
| Sleep study including heart rate, breathing, airflow, and effort | 155 | 154 |
| Critical care, first 30-74 minutes | 139 | 114 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Wichita, KS | 634 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Wichita, KS | 571 |
| Montelukast Sodium Other prescribers in Wichita, KS | 496 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Wichita, KS | 284 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Wichita, KS | 261 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Wichita, KS | 248 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Wichita, KS | 244 |
| Incruse Ellipta (umeclidinium bromide) Other prescribers in Wichita, KS | 153 |
| Roflumilast Other prescribers in Wichita, KS | 147 |
| Prednisone Other prescribers in Wichita, KS | 143 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 80 payments worth $2,072 in total to this clinician.
| GlaxoSmithKline, LLC. | $568 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $562 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $203 |
| Axsome Therapeutics, Inc. | $90.72 |
| United Therapeutics Corporation | $88.52 |
| Actelion Pharmaceuticals US, Inc. | $85.98 |
| Genzyme Corporation | $79.42 |
| Viatris Specialty LLC | $72.41 |
| Food and Beverage | $2,072 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.